Download PDF
Flugmedizin · Tropenmedizin · Reisemedizin - FTR 2008; 15(4): 178-183
DOI: 10.1055/s-0028-1119797
Höhenmedizin

© Georg Thieme Verlag Stuttgart · New York

Der Diabetiker in der Höhe – Extrembergsteigen ist bei guter Vorbereitung möglich

The diabetic at high altitudes – Pathophysiology and practical consequencesBodo Gutt1 , Alexander Wiesmeth1 , Ulrike Thurm2 , Thorsten Siegmund1 , Petra–Maria Schumm–Draeger1 , Rainald Fischer3
  • 1Abteilung für Endokrinologie, Diabetologie und Angiologie, Klinikum Bogenhausen, Städtisches Klinikum München–GmbH(Chefärztin: Prof. Dr. Petra–Maria Schumm–Draeger)
  • 2International Diabetic Athletes Association (IDAA) Deutschland e. V. (1. Vorsitzende: Ulrike Thurm)
  • 3Abteilung für Pneumologie, Campus Innenstadt, Medizinische Klinik der Ludwig–Maximilians–Universität München (Leiter: Prof. Dr. Rudolf Maria Huber)
Further Information

Publication History

Publication Date:
29 December 2008 (online)

Also available at
    Permissions and Reprints

Eine große und sicherlich wachsende Zahl an Diabetikern treibt Sport in den Bergen. Dabei beeinflussen einige Faktoren die Regulation der Blutzuckerhomöostase bei Typ–1–Diabetikern, wie etwa eine nicht vorhersehbare körperliche Belastung, Mahlzeiten, die Wirksamkeit der Insuline, die Präzision der Blutzuckermessgeräte, extreme Temperaturen und schließlich die Höhe selbst. Dieser Artikel möchte den Einfluss von Aufenthalten in extremen Höhen auf die Blutzuckerhomöostase und deren Regulation bei Patienten mit Typ–1–Diabetes beleuchten.

An unknown and probably increasing number of diabetics frequent mountain areas and practice mountain–related sports. Regulation of type–1–diabetes mellitus in the mountains may well be affected by a number of factors such as unpredictable exercise load and meals, the efficiency of insulin and glucose meters, extreme temperatures and altitude itself. This review aims to identify the main issues facing a healthy and well–controlled type–1–diabetic mountaineer at high altitude.

Key words

diabetes mellitus - mountaineering - high altitude - ketoacidosis - acute mountain sickness

Literatur

  • 1 ADA. . American Diabetes Association Position Statement Diabetes Mellitus and Exercise.  Diabetes Care. 2004;  27 58-62
    CrossrefGoogle Scholar
  • 2 Brubaker PL.. Adventure Travel and Type 1 Diabetes.  Diabetes Care. 2005;  28 2563-2572
    CrossrefGoogle Scholar
  • 3 Leal C.. Going High with Type 1 Diabetes.  High Altitude Medicine & Biology. 2005;  6 14-21
    Google Scholar
  • 4 Diamond MP, Hallarman L, Starick–Zych K. et al. . Suppression of counterregulatory hormone response to hypoglycemia by insulin per se.  J Clin Endocrinol Metab. 1991;  72 1388-1390
    CrossrefGoogle Scholar
  • 5 Unger RH, Orci L.. Glucagon and the A cell: physiology and pathophysiology (2nd of 2 parts).  N Engl J Med. 1981;  304 1575-1580
    Google Scholar
  • 6 Rose BD, Post TW.. Clinical physiology of acid–base and electrolyte disorders.  City: McGraw–Hill. 2001;  794 809-815
    Google Scholar
  • 7 Foster DW.. Banting lecture 1984. From glycogen to ketones and back.  Diabetes. 1984;  33 1188-1199
    Google Scholar
  • 8 Miles JM, Haymond MW, Nissen SL, Gerich JE.. Effects of free fatty acid availability, glucagon excess, and insulin deficiency on ketone body production in postabsorptive man.  J Clin Invest. 1983;  71 1554-1561
    CrossrefGoogle Scholar
  • 9 Owen OE, Trapp VE, Skutches CL. et al. . Acetone metabolism during diabetic ketoacidosis.  Diabetes. 1982;  31 242-248
    CrossrefGoogle Scholar
  • 10 Barnholt KS, Hoffman AR, Rock PB. et al. . Endocrine responses to acute and chronic high–altitude exposure (4,300 meters): modulating effects of caloric restriction.  Am J Physiol Endocrinol Metab. 2006;  290 1078-1088
    CrossrefGoogle Scholar
  • 11 Benso A, Broglio F, Aimaretti G. et al. . Endocrine and metabolic responses to extreme altitude and physical exercise in climbers.  Eur J Endocrinol. 2007;  157 733-740
    CrossrefGoogle Scholar
  • 12 Arieff AI, Carroll HJ.. Nonketotic hyperosmolar coma with hyperglycemia: clinical features, pathophysiology, renal function, acid–base balance, plasma–cerebrospinal fluid equilibria and the effects of therapy in 37 cases.  Medicine (Baltimore). 1972;  51 73-94
    CrossrefGoogle Scholar
  • 13 Zierler KL, Rabinowitz D.. Effect of very small concentrations of insulin on forearm metabolism. Persistence of itsaAction on potassium and free fatty acids without its effect on glucose.  J Clin Invest. 1964;  43
    Google Scholar
  • 14 Daugirdas JT, Kronfol NO, Tzamaloukas AH, Ing TS.. Hyperosmolar coma: cellular dehydration and the serum sodium concentration.  Ann Intern Med. 1989;  110 855-857
    Google Scholar
  • 15 Fulop M, Tannenbaum H, Dreyer N.. Ketotic hyperosmolar coma.  Lancet. 1973;  2 635-639
    Google Scholar
  • 16 Lavin PJ.. Hyperglycemic hemianopia: a reversible complication of non–ketotic hyperglycemia.  Neurology. 2005;  65 616-619
    CrossrefGoogle Scholar
  • 17 Umpierrez G, Freire AX.. Abdominal pain in patients with hyperglycemic crises.  J Crit Care. 2002;  17 63-67
    CrossrefGoogle Scholar
  • 18 Adrogue HJ, Lederer ED, Suki WN, Eknoyan G.. Determinants of plasma potassium levels in diabetic ketoacidosis.  Medicine (Baltimore). 1986;  65 163-172
    Google Scholar
  • 19 Bojunga J, Badenhopp K, Althoff PH, Usadel KH.. Akute Stoffwechselentgleisungen. In: Mehnert H, Standl E, Usadel KH, Häring HU, Hrsg. Diabetologie in Klinik und Praxis. 5. Aufl. Stuttgart, New York: Georg Thieme Verlag 2003
    Google Scholar
  • 20 Bilen H, Kilicaslan A, Akcay G, Albayrak F.. Performance of glucose dehydrogenase (GDH) based and glucose oxidase (GOX) based blood glucose meter systems at moderately high altitude.  J Med Eng Technol. 2007;  31 152-156
    CrossrefGoogle Scholar
  • 21 Fanghanel G, Silva U, Sanchez–Reyes L. et al. . Effects of metformin on fibrinogen levels in obese patients with type 2 diabetes comparative accuracy of glucose monitors.  Rev Invest Clin. 1998;  50 389-394
    Google Scholar
  • 22 Gautier JF, Bigard AX, Douce P. et al. . Influence of simulated altitude on the performance of five blood glucose meters.  Diabetes Care. 1996;  19 1430-1433
    CrossrefGoogle Scholar
  • 23 Tang Z, Louie RF, Lee JH. et al. . Oxygen effects on glucose meter measurements with glucose dehydrogenase– and oxidase–based test strips for point–of–care testing.  Crit Care Med. 2001;  29 1062-1070
    Google Scholar
  • 24 Tang Z, Lee JH, Louie RF, Kost GJ.. Effects of different hematocrit levels on glucose measurements with handheld meters for point–of–care testing.  Arch Pathol Lab Med. 2000;  124 1135-1140
    Google Scholar
  • 25 Tang Z, Du X, Louie RF, Kost GJ.. Effects of drugs on glucose measurements with handheld glucose meters and a portable glucose analyzer.  Am J Clin Pathol. 2000;  113 75-86
    CrossrefGoogle Scholar
  • 26 Leal C, Admetlla J, Viscor G, Ricart A.. Diabetic retinopathy at high altitude.  High Alt Med Biol. 2008;  9 24-27
    CrossrefGoogle Scholar
  • 27 Moore K, Vizzard N, Coleman C. et al. . Extreme altitude mountaineering and Type 1 diabetes; the Diabetes Federation of Ireland Kilimanjaro Expedition.  Diabet Med. 2001;  18 749-755
    CrossrefGoogle Scholar

Korrespondenz

Dr. Bodo Gutt

Städtisches Klinikum München–GmbH Klinikum Bogenhausen Abteilung für Endokrinologie, Diabetologie und Angiologie

Englschalkinger Str. 77

81925 München

Email: bodo.gutt@kh-bogenhausen.de

      >